Evidence map›Paper›PMID 38433067›Full record

ArticleEuropean urology focus2024

The Impact of Venous Thromboembolism on Upper Tract Urothelial Carcinomas Undergoing Open or Minimally Invasive Radical Nephroureterectomy in the USA: Perioperative Outcomes and Health Care Costs from Insurance Claims Data.

Anas S Tresh, Francesco Del Giudice, Shufeng Li, Satvir Basran, Federico Belladelli, Ettore De Berardinis, Vincenzo Asero, Matteo Ferro, Sabin Tataru, Gian Maria Busetto and 16 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in European urology focus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 15 institutions in 7 countries.

Anas S TreshDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: atresh@stanford.edu.
Francesco Del GiudiceDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA; Department of Maternal-Infant and Urological Sciences, "Sapienza" Rome University, Policlinico Umberto I Hospital, Rome, Italy.
Shufeng LiDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.
Satvir BasranDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA.
Federico BelladelliDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Ettore De BerardinisDepartment of Maternal-Infant and Urological Sciences, "Sapienza" Rome University, Policlinico Umberto I Hospital, Rome, Italy.
Vincenzo AseroDepartment of Maternal-Infant and Urological Sciences, "Sapienza" Rome University, Policlinico Umberto I Hospital, Rome, Italy.
Matteo FerroDepartment of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
Sabin TataruDepartment of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
Gian Maria BusettoDepartment of Urology and Organ Transplantation, University of Foggia, Foggia, Italy.
Ugo FalagarioDepartment of Urology and Organ Transplantation, University of Foggia, Foggia, Italy.
Riccardo AutorinoDepartment of Urology, Rush University Medical Center, Chicago, IL, USA.
Felice CrocettoDepartment of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
Biagio BaroneDepartment of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
Benjamin PradereDepartment of Urology, La Croix Du Sud Hospital, Quint Fonsegrives, France.
Marco MoschiniDepartment of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
Andrea MariCNR Institute of Neuroscience, Padova, Italy.
Wojciech KrajewskiUniversity Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, Wroclaw, Poland.
Łukasz NowakUniversity Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, Wroclaw, Poland.
Bartosz MałkiewiczUniversity Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, Wroclaw, Poland.
Tomasz SzydełkoUniversity Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, Wroclaw, Poland.
Simone CrivellaroUniversity of Illinois Hospital & Health Sciences System, Chicago, IL, USA.
Abhay RaneEast Surrey Hospital, Redhill, Surrey, UK.
Benjamin ChallacombeGuy's and St. Thomas' NHS Foundation Trust, Guys and St Thomas' Hospital, London, UK.
Rajesh NairDepartment of Neurosurgery, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
Benjamin I ChungDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA.
Stanford University · USWroclaw Medical University · PLPoliclinico Umberto I · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Foggia · ITUniversity of Naples Federico II · ITComprehensive Cancer Center Vienna · ATEast Surrey Hospital · GBEuropean Institute of Oncology · ITGuy's and St Thomas' NHS Foundation Trust · GBKasturba Medical College, Manipal · INLyon Genou Centre Albert Trillat · FRNeuroscience Institute · ITRush University Medical Center · USUniversity of Illinois Chicago · US

Funding

Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0M
NCATS NIH HHS UL1 TR003142
6 · The paper itself

Abstract

BACKGROUND AND

objectiveVenous thromboembolism (VTE) is a significant predictor of worse postoperative morbidity in cancer surgeries. No data have been available for patients with preoperative VTE and upper tract urothelial carcinoma (UTUC) undergoing radical nephroureterectomy (RNU). Our aim was to assess the impact of a preoperative VTE diagnosis on perioperative outcomes in the RNU context.

methodsPatients aged 18 yr or older with a UTUC diagnosis undergoing RNU were identified in the Merative Marketscan Research deidentified databases between 2007 and 2021. Multivariable logistic regression adjusted by relevant perioperative confounders was used to investigate the association between a diagnosis of VTE prior to RNU and 90-d complication rates, postoperative VTE, rehospitalization, and total costs. A sensitivity analysis on VTE severity (pulmonary embolism [PE] and/or deep venous thrombosis [DVT]) was examined. KEY FINDINGS AND LIMITATIONS: Within the investigated cohort of 6922 patients, history of any VTE preceding RNU was reported in 568 (8.21%) cases, including DVT (n = 290, 51.06%), PE (n = 169, 29.75%), and superficial VTE (n = 109, 19.19%). The history of VTE before RNU was predictive of higher rates of complications, the most prevalent being respiratory complications (odds ratio [OR]: 1.78, 95% confidence interval [CI]: 1.43-2.22). Preoperative VTE was found to be associated with an increased risk of VTE following RNU (OR: 14.3, 95% CI: 11.48-17.82), higher rehospitalization rates (OR: 1.26, 95% CI 1.01-1.56) other than home discharge status (OR: 1.44, 95% CI: 1.18-1.77), and higher costs (OR 1.42, 95% CI: 1.20-1.68). Limitations include the retrospective nature and the use of an insurance database that relies on accurate coding and does not include information such as pathologic staging. CONCLUSIONS AND CLINICAL IMPLICATIONS: The presented findings will contribute to the counseling process for patients. These patients may benefit from enhanced pre/postoperative anticoagulation. More research is needed before the following results can be used in the clinical setting. PATIENT SUMMARY: Patients aged 18 yr or older with an upper tract urothelial carcinoma (UTUC) diagnosis undergoing radical nephroureterectomy (RNU) were identified in the Merative Marketscan Research deidentified databases between 2007 and 2021. Multivariable logistic regression adjusted by relevant perioperative confounders was used to investigate the association between a diagnosis of venous thromboembolism (VTE) prior to RNU and 90-d complication rates, postoperative VTE, rehospitalization, and total costs. A sensitivity analysis on VTE severity (pulmonary embolism and/or deep venous thrombosis) was examined. The presented findings will contribute to the counseling of patients with UTUC and preoperative VTE.

Indexed as

Carcinoma, Transitional CellHealth Care CostsKidney NeoplasmsNephroureterectomyPostoperative ComplicationsVenous ThromboembolismAdultAgedFemaleHumansInsurance Claim ReviewMaleMiddle AgedRetrospective StudiesTreatment OutcomeUnited StatesDeep venous thrombosisHealth-related costsPerioperative morbidityPulmonary embolismRadical nephroureterectomyVenous thromboembolism

Identifiers

PMID38433067
PMCPMC11602270
OpenAlexW4392347949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.